Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status
C.S. Thomson, C.J. Twelves, E.A. Mallon, R.E. LeakeVolume:
11
Year:
2002
Language:
english
Pages:
11
DOI:
10.1054/brst.2002.0451
File:
PDF, 174 KB
english, 2002